Duke Cancer Center Raleigh — Raleigh, North Carolina

Duke Cancer Center Raleigh is a clinical research site located in Raleigh, North Carolina, United States 27609.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Duke Cancer Center Raleigh has participated in 43 clinical trials with 40 currently active.

Therapeutic areas: Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.

Sponsors: National Cancer Institute (NCI), NRG Oncology, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Cancer Center Raleigh?

Duke Cancer Center Raleigh has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Cancer Center Raleigh conducted?

Duke Cancer Center Raleigh has 43 clinical trials on record, with 40 currently active. Their work covers Stage IB Lung Non-Small Cell Carcinoma AJCC v7, Stage II Lung Non-Small Cell Cancer AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7.

Is Duke Cancer Center Raleigh accredited by Crixeo Health?

Yes — Duke Cancer Center Raleigh holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Duke Cancer Center Raleigh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.